Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia
Clinical trial NCT00813826 · UNKNOWN
Trial details
- NCT number
- NCT00813826
- Sponsor
- Solace Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.